MINDSPIRE LIMITED

Active Tunbridge Wells

Research and experimental development on biotechnology

4 employees website.com
Healthcare and wellbeing Research and experimental development on biotechnology
M

MINDSPIRE LIMITED

Research and experimental development on biotechnology

Founded 30 Oct 2018 Active Tunbridge Wells, United Kingdom 4 employees website.com
Healthcare and wellbeing Research and experimental development on biotechnology
Accounts Submitted 18 Dec 2025 Next due 31 Jul 2027 14 months remaining
Confirmation Submitted 19 Apr 2026 Next due 19 Apr 2027 11 months remaining
Net assets £-77K £21K 2024 year on year
Total assets £35K £16K 2024 year on year
Total Liabilities £112K £5K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Napier House 14-16 Mount Ephraim Road Tunbridge Wells TN1 1EE United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for MINDSPIRE LIMITED (11649630), an active healthcare and wellbeing company based in Tunbridge Wells, United Kingdom. Incorporated 30 Oct 2018. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2019–2024)

Cash in Bank

£13.80k

Net Assets

-£76.89k

Decreased by £21.16k (-38%)

Total Liabilities

£111.74k

Increased by £5.21k (+5%)

Turnover

N/A

Employees

4

Increased by 2 (+100%)

Debt Ratio

321%

Increased by 111 (+53%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Grants 1

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

4 Allotments 1,099 Shares £31k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
4 Apr 2023188£8k£40
10 Aug 2022201£8k£40
5 Apr 2022375£15k£40
1 Apr 2022335£335£1

Officers

Officers

1 active 2 resigned
Status
Steffert, Tony Canute, DrDirectorNew ZealanderEngland612 Jul 2021Active

Shareholders

Shareholders (19)

Jane Rebecca Ollis
52.0%
2,961,096
Tony Steffert
22.8%
1,300,000

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Jane Rebecca Ollis

British

Active
Notified 30 Oct 2018
Residence England
DOB April 1968
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
19 Apr 2026OfficersTermination of Amir Konigsberg as director on 1 Apr 2026
19 Apr 2026OfficersAppointment of Mr Eliot Frazier as director on 6 Apr 2026
19 Apr 2026Confirmation StatementConfirmation statement made on 5 Apr 2026 with updates
28 Dec 2025CapitalAllotment of shares (GBP 605.1746) on 25 Nov 2025
18 Dec 2025AccountsAnnual accounts made up to 31 Oct 2025
19 Apr 2026 Officers

Termination of Amir Konigsberg as director on 1 Apr 2026

19 Apr 2026 Officers

Appointment of Mr Eliot Frazier as director on 6 Apr 2026

19 Apr 2026 Confirmation Statement

Confirmation statement made on 5 Apr 2026 with updates

28 Dec 2025 Capital

Allotment of shares (GBP 605.1746) on 25 Nov 2025

18 Dec 2025 Accounts

Annual accounts made up to 31 Oct 2025

Recent Activity

Latest Activity

Termination of Amir Konigsberg as director on 1 Apr 2026

3 weeks ago on 19 Apr 2026

Appointment of Mr Eliot Frazier as director on 6 Apr 2026

3 weeks ago on 19 Apr 2026

Confirmation statement made on 5 Apr 2026 with updates

3 weeks ago on 19 Apr 2026

Allotment of shares (GBP 605.1746) on 25 Nov 2025

4 months ago on 28 Dec 2025

Annual accounts made up to 31 Oct 2025

4 months ago on 18 Dec 2025